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The World Health Organization has rated multidrug-resistant (MDR) Gram-negative bacteria including 
Pseudomonas aeruginosa (Psae) as serious threat to human health. We here addressed whether 
chronic murine gut inflammation facilitates intestinal MDR Psae colonization and whether bacterial 
infection subsequently worsens colonic immunopathology. Converse to wildtype counterparts, Psae 
colonized the intestines of IL-10−/− mice with chronic colitis following peroral challenge, but did not 
lead to changes in intestinal microbiota composition. Psae infection accelerated both macroscopic (i.e. 
clinical) and microscopic disease (i.e. colonic epithelial apoptosis), that were accompanied by increased 
intestinal pro-inflammatory immune responses as indicated by elevated colonic numbers of innate 
and adaptive immune cell subsets and enhanced secretion of pro-inflammatory cytokines such as TNF 
and IFN-γ in mesenteric lymph nodes of Psae-infected as compared to unchallenged IL-10−/− mice. 
Remarkably, Psae-induced pro-inflammatory immune responses were not restricted to the gut, but 
could also be observed systemically as indicated by increased TNF and IFN-γ concentrations in sera 
upon Psae-infection. Furthermore, viable commensals originating from the intestinal microbiota 
translocated to extra-intestinal compartments such as liver, kidney and spleen of Psae-infected IL-10−/− 
mice with chronic colitis only. Hence, peroral MDR Psae-infection results in exacerbated colonic as well 
as systemic pro-inflammatory immune responses during chronic murine colitis.
Pseudomonas aeruginosa (Psae), constitute opportunistic pathogens, that may cause a variety of nosocomial 
infections particularly in immunocompromised patients or patients with chronic pulmonary diseases such as 
chronic obstructive pulmonary disease or cystic fibrosis1–4. Patients suffering from ventilator-associated pneu-
monia or burn wound infections face high mortality rates of over 30%1. As Gram-negative bacteria with emerging 
antimicrobial resistance Psae are among several multi-drug resistant (MDR) bacterial species that can be found 
in a global priority pathogen list issued by the World Health Organization (WHO) in order to help prioritizing 
the development of novel antimicrobial strategies5. Already early studies suggest that besides contaminated res-
pirators and other medical equipment the human gastrointestinal tract might be an important internal source of 
Psae infection in hospitals6,7. Furthermore, a recent study revealed that a majority of intensive care unit (ICU) 
patients with a Psae infection displayed prior rectal colonization with the bacterial opportunistic pathogen8. 
Particularly a preceding antimicrobial treatment had been shown to disturb the complex intestinal microbiota 
composition and therefore to compromise the physiological colonization resistance9–12 which, in turn, may enable 
invading (opportunistic) pathogens including MDR Psae to establish within the human gastrointestinal ecosys-
tem13. However, valid scientific data concerning the pathogenic potential of Psae infection of the intestinal tract 
are scarce. Our very recent study revealed for the first time that mere intestinal carriage of a clinical MDR Psae 
isolate by otherwise healthy microbiota-depleted wildtype (WT) mice resulted in distinct local as well as systemic 
pro-inflammatory immune responses13. We were further able to demonstrate that with intestinal inflammation 
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associated gut microbiota shifts facilitated murine infection with the enteropathogen Campylobacter jejuni14–17. 
Information whether intestinal inflammation may also facilitate stable Psae colonization and may even worsen 
the outcome of the underlying disease are scarce, however. In the present study, we therefore perorally chal-
lenged conventionally colonized IL-10−/− suffering from chronic colitis with a clinical MDR Psae isolate and 
assessed intestinal colonization properties of the opportunistic pathogen, shifts in gut microbiota composition, 
Psae-induced intestinal and systemic pro-inflammatory infectious sequelae, and translocation of viable bacte-
ria to extra-intestinal including systemic compartments. In summary, our data indicate that peroral MDR Psae 
infection exacerbates macroscopic and colonic apoptotic sequelae as well as systemic pro-inflammatory immune 
responses during chronic murine colitis.
Results
Chronic colitis facilitates intestinal MDR P. aeruginosa infection of mice. Conventional IL-10−/− 
mice with chronic colitis and healthy WT control animals were perorally infected with 109 colony-forming units 
(CFU) of a clinical MDR Psae strain. Whereas WT mice had expelled the pathogen within one week p.i., IL-10−/− 
mice displayed higher fecal Psae loads than their WT counterparts as early as 48 hours p.i. (p < 0.001; Fig. 1a). 
Even six weeks thereafter, Psae could be isolated from the gastrointestinal tract of IL-10−/−, but not WT mice 
(p < 0.05–0.001; Fig. 1b) with most frequent abundances of approximately 79% in the large intestinal tract of 
IL-10−/− mice at day 42 p.i. (Fig. 1b).
Given potential crosstalk between (opportunistic) pathogens and commensals, we furthermore addressed 
whether Psae association of IL-10−/− mice was accompanied by shifts in intestinal microbiota composition. 
Both cultural and culture-independent (i.e. molecular 16S rRNA based) analyses of fecal samples revealed that 
IL-10−/− mice with chronic colitis harbored comparable intestinal loads of the main intestinal bacterial groups 
Figure 1. Fecal P. aeruginosa loads over time following peroral infection of mice suffering from chronic colitis. 
Conventionally colonized IL-10−/− mice with chronic colitis (black circles) were perorally infected with a 
multidrug-resistant P. aeruginosa strain on day (d) 0. Wildtype mice without large intestinal inflammation 
(white circles) served as (infected) controls. (a) Intestinal colonization densities were determined in fecal 
samples until d28 postinfection by culture and expressed as colony forming units per gram (CFU/g). (b) 
Upon necropsy at day 42 postinfection, pathogenic loads were cultured from distinct compartments of the 
gastrointestinal tract (i.e. stomach, duodenum, ileum and colon). Numbers of mice harboring P. aeruginosa 
out of the total number of analyzed mice, medians (black bars) and significance levels (p-values) determined 
by Mann Whitney U test are indicated (*p < 0.05; ***p < 0.001). Data shown were pooled from at least three 
independent experiments.
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before and 42 days after Psae challenge (Fig. 2). Hence, chronic IL-10−/− colitis facilitates intestinal infection with 
MDR Psae that does not lead to changes in gut microbiota composition.
Macroscopic and microscopic sequelae in MDR P. aeruginosa infected mice with chronic 
colitis. We next surveyed macroscopic (i.e. clinical) and microscopic (i.e. histopathological and immuno-
histochemical) sequelae in Psae infected IL-10−/− mice with chronic colitis. Whereas 20% of mice from both 
the infected and naive cohort of IL-10−/− mice displayed macroscopic and/or microscopic abundances of 
blood in their feces at day 0 (i.e. immediately before Psae infection), overall fecal blood positivity rates were 
higher in infected as compared to uninfected mice when surveyed until day 42 following bacterial challenge 
(Supplementary Information). Of note, mean body weights of mice in the Psae infected and uninfected cohort 
did neither differ at day 0 nor at day 42 p.i. (Supplementary Information). Given that intestinal inflammation is 
accompanied by significant shortening of the inflamed intestine18, we measured colonic lengths upon necropsy. 
A trend towards shorter large intestines could be observed in Psae infected as compared to uninfected mice at day 
42 p.i.; the difference, however, did not reach statistical significance due to high standard deviations in respec-
tive groups (Supplementary Information). We further quantitatively assessed colonic histomorphological seque-
lae of Psae infection in IL-10−/− mice applying a standardized histopathological scoring system19. Psae infected 
and uninfected mice with chronic colitis displayed comparable histopathological scores at day 42 p.i., indicative 
for mild inflammatory cell infiltrates in the mucosa with mild hyperplasia and goblet cell loss (Supplementary 
Information).
Given that apoptosis constitutes an established parameter for histopathological evaluation and grading of 
intestinal inflammation11, we next quantitatively assessed apoptotic colonic epithelial cells applying in situ immu-
nohistochemistry. Six weeks following Psae infection IL-10−/− mice displayed more two times higher apoptotic 
cell numbers in their large intestines as compared to uninfected counterparts (p < 0.001; Fig. 3a, Supplementary 
Figure 2. Intestinal microbiota composition following multidrug-resistant P. aeruginosa infection of mice 
suffering from chronic colitis. IL-10−/− mice with chronic colitis (n = 19) were perorally infected with a 
multidrug-resistant P. aeruginosa strain on day (d) 0. Before (N, naive; white circles) and six weeks thereafter 
(d42 postinfection; black circles) a comprehensive survey of the intestinal microbiota composition was 
performed on fecal samples applying both (a) culture (expressed as colony forming units per gram, CFU/g) and 
(b) 16S rRNA based molecular analyses (expressed as gene numbers per ng DNA) of the total bacterial load 
(TL) and main intestinal bacterial groups including enterobacteria (EB), enterococci (EC), lactobacilli (LB), 
Bacteroides/Prevotella spp. (BP), Clostridium/Eubacterium spp. (CE), bifidobacteria (BB), Clostridium coccoides 
group, Clostridium leptum group (CL) and Mouse Intestinal Bacteroides (MIB). Medians are indicated. Data 
shown were pooled from three independent experiments.
www.nature.com/scientificreports/
4SCIentIFIC RepoRtS |  (2018) 8:6685  | DOI:10.1038/s41598-018-25034-2
Information). Numbers of Ki67+ colonic epithelial cells, however, did not differ in infected and naive mice (n.s.; 
Fig. 3b, Supplementary Information), thus indicating comparable proliferative/regenerative properties of the 
large intestinal epithelia in either murine cohort. Hence, Psae infection accelerates both macroscopic (i.e. clinical) 
and microscopic (i.e. colonic apoptotic) sequelae in IL-10−/− mice suffering from chronic colitis.
Intestinal immune responses in MDR P. aeruginosa infected mice with chronic colitis. In the 
following we quantitatively assessed large intestinal immune cell responses upon Psae infection of IL-10−/− mice 
with chronic colitis applying in situ immunohistochemistry. Within 42 day p.i., numbers of distinct innate as well 
as of adaptive immune cell subsets including macrophages and monocytes as well as T lymphocytes, regulatory 
T cells (Treg) and B lymphocytes, respectively, increased in the large intestinal mucosa and lamina propria of 
IL-10−/− mice (p < 0.005–0.001; Fig. 4, Supplementary Information). Psae-induced increases in large intestinal 
immune responses were accompanied by elevated secretion of pro-inflammatory cytokines such as TNF and 
IFN-γ in mesenteric lymph nodes (MLN) of IL-10−/− mice (p < 0.05; Fig. 5a,b), whereas MCP-1 and IL-6 con-
centration were comparable in Psae infected and uninfected mice at day 42 p.i. (Fig. 5c,d). Hence, MDR Psae col-
onization of IL-10−/− mice with chronic colitis is accompanied by increased intestinal pro-inflammatory cytokine 
responses.
Systemic immune responses in MDR P. aeruginosa infected mice with chronic colitis. We next 
assessed whether Psae-induced intestinal pro-inflammatory immune responses in mice suffering from chronic 
colitis could also be observed in systemic compartments such as spleen and serum. Whereas a trend towards 
lower TNF and IFN-γ levels could be observed in spleens of infected versus uninfected mice with colitis (n.s.; 
Fig. 6a,b), lower MCP-1 and IL-6 concentrations could be measured in splenic ex vivo biopsies at day 42 p.i. as 
compared to naive IL-10−/− mice (p < 0.01; Fig. 6c,d), Conversely, Psae infection resulted in more pronounced 
secretion of pro-inflammatory cytokines into the circulation as indicated by higher TNF and IFN-γ (p < 0.05; 
Fig. 7a,b), but comparable MCP-1 and IL-6 concentrations in serum samples derived from infected as compared 
to uninfected mice with chronic colitis (n.s.; Fig. 7c,d). Hence, MDR Psae-induced pro-inflammatory immune 
responses were not restricted to the intestinal tract, but could also be observed systemically.
Bacterial translocation in MDR P. aeruginosa infected mice with chronic colitis. We finally sur-
veyed whether bacteria originating from the commensal intestinal microbiota had translocated to extra-intestinal 
and systemic compartments of Psae colonized IL-10−/− mice. Whereas no bacterial translocation could be 
observed in uninfected mice with chronic colitis at all, viable intestinal commensal bacteria such as lactoba-
cilli, enterococci, E. coli, Bacteroides/Prevotella species and Clostridium/Eubacterium species could be cultured 
from MLN, spleen, liver and kidney in 31.6%, 10.5%, 26.3% and 15.8% of infected IL-10−/− mice, respectively 
(Supplementary Information). Notably, neither in blood of naive nor Psae infected mice with colitis any bac-
teria could be detected. Hence, viable commensals originating from the intestinal microbiota translocated to 
extra-intestinal compartments of MDR Psae colonized IL-10−/− mice with chronic colitis only.
Figure 3. Apoptotic and proliferating colonic epithelial cells in multidrug-resistant P. aeruginosa infected mice 
suffering from chronic colitis. IL-10−/− mice with chronic colitis were perorally infected with a multidrug-
resistant P. aeruginosa (Psae) strain on day (d) 0. Six weeks thereafter (on d42 postinfection; black circles) 
the average numbers of colonic epithelial (a) apoptotic (positive for caspase 3, Casp3) and (b) proliferating 
cells (positive for Ki67) were determined from six high power fields (HPF, 400x magnification) per animal 
in immunohistochemically stained large intestinal paraffin sections. Naive (N) IL-10−/− mice served as 
negative controls (open circles). Numbers of mice (in parentheses), medians (black bars) and significance 
levels (p-values) determined by the Mann Whitney U test are indicated. Data shown were pooled from three 
independent experiments.
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Taken together, peroral MDR Psae infection exacerbates macroscopic and colonic apoptotic sequelae as well as 
intestinal and systemic pro-inflammatory cytokine responses in IL-10−/− mice with chronic colitis.
Discussion
The rising increases in incidences of MDR bacterial Gram-negative strains including Psae colonizing and infect-
ing humans as well as live stock animals all over the world have resulted in an increased awareness not only of 
health care professionals, but also of the general public and the political institutions for this global threat of 
human health and for the actually very limited strategies preventing morbidity and mortality2,5,20. It is thus rather 
surprising, however, that studies addressing the immunopathological consequences of intestinal colonization 
and infection of vertebrates with Psae in health and disease including intestinal inflammation are scare to date.
In an earlier study, ingested Psae were detectable in three healthy volunteers up to 6 days thereafter, but with-
out any reported adverse effects7. Very recently we were able to show that upon peroral challenge with the same 
clinical MDR Psae isolate used in the present survey, healthy WT mice with a virtually depleted gut microbiota 
following broad-spectrum antibiotic treatment harbored the opportunistic pathogen at high loads in their gas-
trointestinal tract, but were clinically uncompromised13. This observation is well in line with a previous report 
Figure 4. Colonic immune cell responses in multidrug-resistant P. aeruginosa infected mice suffering 
from chronic colitis. IL-10−/− mice with chronic colitis were perorally infected with a multidrug-resistant P. 
aeruginosa (Psae) strain on day (d) 0. Six weeks thereafter (on d42 postinfection; black circles) the average 
numbers of colonic (a) macrophages and monocytes (positive for F4/80), (b) T lymphocytes (positive for CD3), 
(c) regulatory T cells (positive for FOXP3), and (d) B lymphocytes (positive for B220) were determined from 
six high power fields (HPF, 400x magnification) per animal in immunohistochemically stained large intestinal 
paraffin sections. Naive (N) IL-10−/− mice served as negative controls (open circles). Numbers of mice (in 
parentheses), medians (black bars) and significance levels (p-values) determined by the Mann Whitney U test 
are indicated. Data shown were pooled from three independent experiments.
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by Hentgens et al., given that following antibiotic treatment and subsequent Psae infection mice were clinically 
unaffected9.
Despite the well-known arsenal of virulence factors and hence pathogenic properties of Psae, its poten-
tial in initiating and perpetuating pre-existing immunopathological morbidities, particularly in the gastroin-
testinal tract, is only incompletely understood13. Recent surveys revealed that the opportunistic pathogen was 
more abundant in the gastrointestinal tract of patients suffering from underlying intestinal morbidities such 
as ulcerative colitis21 or irritable bowel syndrome22. Remarkably, in our recent study MDR Psae induced pro-
nounced pro-inflammatory sequelae in both intestinal and extra-intestinal including systemic compartments in 
antibiotics-pretreated, but otherwise healthy mice13. In addition, we were able to show in another recent survey 
that acute small intestinal inflammation facilitated MDR Psae acquisition by mice harboring a human gut micro-
biota23. The applied inflammation model was, however, too acute to decipher additional inflammatory sequelae 
of the applied Psae strain.
In the present study we further showed that chronic colitis in conventionally colonized IL-10−/− mice (that 
had not been subjected to antibiotic pretreatment) did not only facilitate murine MDR Psae carriage, but also 
worsened distinct features of the underlying disease as shown on both macroscopic (i.e. clinical) and microscopic 
Figure 5. Intestinal cytokine responses in multidrug-resistant P. aeruginosa infected mice suffering from 
chronic colitis. IL-10−/− mice with chronic colitis were perorally infected with a multidrug-resistant 
P. aeruginosa (Psae) strain on day (d) 0. Six weeks thereafter (on d42 postinfection; black circles) pro-
inflammatory cytokines including (a) TNF, (b) IFN-γ, (c) MCP-1 and (d) IL-6 were measured in supernatants 
of ex vivo biopsies derived from mesenteric lymph nodes (MLN). Naive (N) IL-10−/− mice served as negative 
controls (open circles). Numbers of mice (in parentheses), medians (black bars) and significance levels 
(p-values) determined by the Mann Whitney U test are indicated. Data shown were pooled from three 
independent experiments.
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levels. In fact, Psae-colonized IL-10−/− mice more frequently presented with blood in their feces and exhibited 
more pronounced colonic apoptosis that were accompanied by higher abundances of innate as well as adap-
tive immune cell populations in the inflamed colonic mucosa and lamina propria and increased secretion of 
the pro-inflammatory cytokines TNF and IFN-γ in MLN. Remarkably, accelerated disease was not restricted to 
the intestinal tract but could also be observed systemically, given that Psae-colonized IL-10−/− mice displayed 
elevated TNF and IFN-γ serum levels. Increased systemic pro-inflammatory cytokines were accompanied by 
translocation of viable commensal bacteria originating from the intestinal microbiota to extra-intestinal com-
partments of MDR Psae-colonized IL-10−/− mice. This indicates that additional acquisition of the opportunistic 
pathogen by colitic mice compromised intestinal barrier function subsequently facilitating bacterial spread from 
the leaky gut. Surprisingly, pro-inflammatory cytokine concentrations were lower in the spleen of Psae carrying 
IL-10−/− mice as compared to non-carriers. This might be explained by increased recruitment of leukocytes from 
the spleen to the inflamed intestinal tract.
In our present survey, Psae could be isolated from the intestines in up to 80% of IL-10−/− mice suffering from 
chronic colitis, even though mice harbored a conventional gut microbiota that usually protects mice from invad-
ing (opportunistic) pathogens11. One needs to take into consideration, however, that intestinal inflammatory 
Figure 6. Splenic cytokine responses in multidrug-resistant P. aeruginosa infected mice suffering from chronic 
colitis. IL-10−/− mice with chronic colitis were perorally infected with a multidrug-resistant P. aeruginosa 
(Psae) strain on day (d) 0. Six weeks thereafter (on d42 postinfection; black circles) proinflammatory cytokines 
including (a) TNF, (b) IFN-γ, (c) MCP-1 and (d) IL-6 were determined in supernatants of splenic ex vivo 
biopsies. Naive (N) IL-10−/− mice served as negative controls (open circles). Numbers of mice (in parentheses), 
medians (black bars) and significance levels (p-values) determined by the Mann Whitney U test are indicated. 
Data shown were pooled from three independent experiments.
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conditions per se might facilitate pathogenic colonization, given that the increased intraluminal abundance of cell 
debris, for instance, may serve as valuable nutrient sources for specific invading bacteria and may thus provide 
growth advantages in direct competition with the complex intestinal microbiota for nutrients and niches16,17,23,24. 
Furthermore, both acute and chronic inflammation of the small and large intestines are accompanied by distinct 
changes in murine microbiota composition providing growth benefits for certain intestinal commensals such 
as enterobacteria24–27, which in turn might change the intraluminal milieu in favor of distinct (opportunistic) 
pathogenic species. In line, our previous studies revealed that elevated intestinal loads of commensal Escherichia 
coli were sufficient to override physiological colonization resistance and to facilitate murine infection with the 
enteropathogen Campylobacter jejuni14–16,28.
Given a potential (bi-directional) crosstalk between (opportunistic) pathogens and intestinal commensals 
we performed a comprehensive survey of the large intestinal microbiota composition before and after MDR Psae 
challenge applying both culture and culture-independent (molecular) methods. Interestingly, a 6-week intestinal 
MDR Psae carriage by IL-10−/− with chronic colitis did not alter the microbiota within the inflamed colon lumen.
In conclusion, we here show that peroral MDR Psae challenge results in intestinal infection that exacerbates 
chronic colitis as indicated by macroscopic and colonic apoptotic sequelae as well as intestinal and systemic 
Figure 7. Systemic cytokine responses in multidrug-resistant P. aeruginosa infected mice suffering from 
chronic colitis. IL-10−/− mice with chronic colitis were perorally infected with a multidrug-resistant 
P. aeruginosa (Psae) strain on day (d) 0. Six weeks thereafter (on d42 postinfection; black circles) pro-
inflammatory cytokines including (a) TNF, (b) IFN-γ, (c) MCP-1 and (d) IL-6 were determined in serum. Naive 
(N) IL-10−/− mice served as negative controls (open circles). Numbers of mice (in parentheses), medians (black 
bars) and significance levels (p-values) determined by the Mann Whitney U test are indicated. Data shown were 
pooled from three independent experiments.
www.nature.com/scientificreports/
9SCIentIFIC RepoRtS |  (2018) 8:6685  | DOI:10.1038/s41598-018-25034-2
pro-inflammatory cytokine responses in IL-10−/− mice. In ongoing studies we are currently unraveling the 
distinct intraluminal factors favoring and preventing intestinal MDR Psae establishment in health and dis-
ease. This may provide novel antibiotics-independent approaches to prevent intestinal colonization with MDR 
Gram-negative species including Psae in vertebrates and to combat subsequent infections of the susceptible host 
at risk including immunocompromized patients or individuals suffering from intestinal immunopathological 
morbidities.
Material and Methods
Ethical statement. In accordance with the European Guidelines for animal welfare (2010/63/EU), mice 
were reared, maintained and twice daily monitored assessing clinical conditions and weight loss. The commission 
for animal experiments headed by the “Landesamt für Gesundheit und Soziales” (LaGeSo, Berlin; registration 
number G0097/12 and G0039/15) had given approval before start of animal experiments.
Mice and P. aeruginosa infection. Approximately 4 months old conventionally colonized, female IL-10−/− 
mice with chronic colitis (in C57BL/6j background) and corresponding WT mice were raised in the specific path-
ogen free unit of the Forschungseinrichtungen für Experimentelle Medizin (FEM, Charité – University Medicine 
Berlin) and perorally infected with 109 CFU of a MDR Psae strain as described earlier13,23,29 In brief, the Psae 
isolate had been initially isolated from respiratory fluid of a patient with nosocomial pneumonia and exhibited 
antimicrobial sensitivity towards colistin and fosfomycin only (provided by Prof. Dr. Bastian Opitz, Charité – 
University Medicine, Berlin, Germany). The MDR bacterial strain was applied in a total volume of 0.3 mL phos-
phate buffered saline (PBS; Gibco, life technologies, UK) to mice by oral gavage.
Cultural analysis of P. aeruginosa. Fecal and luminal samples from stomach, duodenum, ileum and colon 
were plated in serial dilutions onto Columbia agar supplemented with 5% sheep blood (Oxoid, Germany) and 
Cetrimide agar (Oxoid, Germany) after homogenization in sterile PBS13,23,29. Inoculated agar plates were then 
incubated in an aerobic atmosphere at 37 °C for 48 h to assess Psae loads after infection as described earlier13,23,29.
Clinical conditions. On a daily basis, fecal samples derived from each mouse were screened for abundance 
of fecal blood by the Guajac method (Haemoccult, Beckman Coulter/PCD, Germany) as reported previously18,29.
Sampling procedures. Six weeks following Psae infection mice were sacrifized by isoflurane inhalation 
(Abott, Germany). Cardiac blood and tissue samples from spleen, liver, lung, kidney, MLN, ileum and colon were 
collected under sterile conditions as described earlier13,23,29. After measuring the large intestinal lengths, colonic 
tissue samples were collected in parallel for histopathological and immunohistochemical analyses as well as for 
cytokine measurements.
Histopathology and immunohistochemistry. Histopathological changes observed in 5 µm thin hema-
toxylin and eosin stained colonic paraffin sections were quantitated applying a standardized histopathological 
scoring system ranging from 0 to 4 as described by Erben et al.19. In brief: Score 0: unaffected histomorphology. 
Score 1: minimal inflammatory cell infiltrates in the mucosa with intact epithelium. Score 2: mild inflammatory 
cell infiltrates in the mucosa with mild hyperplasia and mild goblet cell loss. Score 3: moderate inflammatory cell 
infiltrates in mucosa and submucosa with moderate goblet cell loss. Score 4: marked inflammatory cell infiltration 
into mucosa and submucosa with marked hyperplasia and marked goblet cell loss, multiple crypt abscesses and 
crypt loss19.
To display immune cell response in colonic ex vivo biopsies, immunohistochemical staining was performed 
on five-µm paraffin sections as described earlier13,23,27,29–32. In short, primary antibodies against cleaved caspase-3 
(Asp175, #9661, Cell Signaling, Netherlands; 1:200) for apoptitic cells, Ki67 (clone 16A8, #652401, BioLegend/
Biozol, Germany; 1:200) for proliferating/regenerating cells, F4/80 (clone BM8, #MF48015, Life Technologies, 
Germany; 1:100) for macrophages/monocytes, CD3 (#IR50361-2, Dako, USA; 1:5) for T lymphocytes, FOXP3 
(clone FJK-165, #14–5773, eBioscience, Germany; 1:100) for Tregs and B220 (#14-0452-81, eBioscience; 1:200) 
for B lymphocytes were used. The average number of positively stained cells within at least six high power fields 
(HPF, 0.287 mm2; 400x magnification) were determined by a blinded independent investigator.
Cultural survey of intestinal microbiota and bacterial translocation. To survey the composition of 
the commensal colonic microbiota and the abundance of viable commensals of intestinal origin that had translo-
cated to extra-intestinal including systemic sites, colonic luminal contents and tissue samples derived from MLN, 
spleen, liver, kidney and lung were homogenized in sterile PBS, streaked out in serial dilutions on agar plates 
and incubated under aerobic, microaerobic and anaerobic conditions at 37 °C for two to three days as reported 
earlier23,24,32,33. The detection limit of viable bacteria was approximately 100 CFU per g. To assess the appearance 
of bacteremia, thioglycolate enrichment broths (BD Bioscience, Germany) were inoculated with cardiac blood 
of individual mice and incubated for seven days at 37 °C and subsequently streaked onto respective agares for 
further identification as described23,32.
Molecular analysis of the intestinal microbiota. The numbers of 16S rRNA gene copies per ng DNA 
of main bacterial groups abundant in the murine and human gut microbiota were quantified applying quantita-
tive real-time polymerase chain reaction with species-, genera- or group-specific 16S rRNA gene primers (Tib 
MolBiol, Germany) as stated elsewhere11,27,34. In brief, DNA was extracted from individual fecal samples, quanti-
fied by using Quant-iT PicoGreen reagent (Invitrogen, UK) and adjusted to 1 ng per µl24,35,36.
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Cytokine detection. Tissue samples of MLN and spleen were transferred to 24-well-flat-bottom culture 
plates (Falcon, Germany) and incubated in 500 μL serum-free RPMI 1640 medium (Gibco, life technologies) sup-
plemented with penicillin (100 U/mL, Biochrom, Germany) and streptomycin (100 µg/mL; Biochrom) for 18 h at 
37 °C. TNF, IFN-γ, MCP-1, and IL-6 concentrations were measured in supernatants and serum samples applying 
the Mouse Inflammation Cytometric Bead Assay (CBA; BD Bioscience) on a BD FACSCanto II flow cytometer 
(BD Bioscience) as stated elsewhere11,23.
Statistical analysis. Mean values, medians, and levels of significance were determined using 
Mann-Whitney-U Test. Two-sided probability (p) values ≤ 0.05 were considered significant. Experiments were 
repeated at least twice.
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